StockSelector.com
  Research, Select, & Monitor Tuesday, May 22, 2018 5:41:03 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Paratek Pharmaceuticals Inc.$11.10($.40)(3.48%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Paratek Pharmaceuticals Inc. has an overall rank of 6937 out of 6982 stocks based on 6 positive rankings and 9 negative rankings.

Positive Rankings
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Paratek Pharmaceuticals Inc. is ranked 425.
Low Put/Call
Paratek Pharmaceuticals Inc. has a low Put/Call ratio of 0.41 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Paratek Pharmaceuticals Inc. is ranked 824.
Historic Revenue Growth
Paratek Pharmaceuticals Inc. rank is 1880
Debt-to-Equity
Paratek Pharmaceuticals Inc. rank is 1941
10 Day Gain
Paratek Pharmaceuticals Inc. rank is 1976
Up EPS Surprise
Paratek Pharmaceuticals Inc. beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative Cash Growth
Paratek Pharmaceuticals Inc. rank is 133
Negative Net Margin
Paratek Pharmaceuticals Inc. rank is 214
Price-to-Sales
Paratek Pharmaceuticals Inc. rank is 250
Negative ROE
Paratek Pharmaceuticals Inc. rank is 298
90 Day Loss
Paratek Pharmaceuticals Inc. rank is 357
High vPut/Call
Paratek Pharmaceuticals Inc. has a high Put/Call ratio of 0.14 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Paratek Pharmaceuticals Inc. is ranked 458.
Negative ROA
Paratek Pharmaceuticals Inc. rank is 481
Down EPS Surprise
Paratek Pharmaceuticals Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
Paratek Pharmaceuticals Inc. rank is 1152







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.